trs005
mAbexperimentalADC
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2025 (NCT07035379)
Timeline
Indications
Mechanism of action
MS4A4A inhibitor
Chemistry & pharmacology
- Payload
- MMAE
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06886139 | Phase 2 | Sep 30, 2025 | Chinese Academy of Medical Sciences, Zhejiang Teruisi Pharmaceutical Inc. |
| NCT07035379 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2025 | Zhejiang Teruisi Pharmaceutical Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang Teruisi Pharmaceutical Inc. | For profit | 2 | 2 | 1 | 2025 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1